Exploring Lessons Learned from a Century of Outbreaks Readiness for 2030: Proceedings of a Workshop (2019) / Chapter Skim
Currently Skimming:
Appendix E: Biographical Sketches of Pre-Workshop and Workshop Speakers and Moderators
Appendix E: Biographical Sketches of Pre-Workshop and Workshop Speakers and Moderators
Pages 191-210
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 191... ...
He oversees the advanced development and procurement of medical countermeasures against an array of threats to national security and the public's health, including chemical, biological, radiological, nuclear threats and pandemic influenza, and emerging infectious diseases.
|
From page 192... ...
Dr. Bright joined BARDA in 2010, and prior to becoming director in late 2016, he served as director of BARDA's Influenza and Emerging Infectious Diseases Division.
|
From page 193... ...
C urrently, he is a member of the Board of the Singapore Health System, member of the Health Biomedical Sciences International Advisory Council of ingapore, and Advisory Council of the Imperial College Health Partners, S UK. He chairs the International Scientific Advisory Committee of the Qatar Genome Project, chairs the Scientific Boards of the Peter Munk Cardiac Center, University of Toronto, and Institute of Cardiovascular and Medical Sciences, University of Glasgow.
|
From page 194... ...
Fauci, M.D., is director of the National Institute of Allergy and Infectious Diseases (NIAID)
|
From page 195... ...
He helped found and served as president of the Society for Medical Decision Making and chaired the World Health Organization Committee to Review the International Health Regulations (2005) and Response to Pandemic Influenza A (H1N1)
|
From page 196... ...
Dr. Fukuda has been a global public health leader in many areas, including health security; emerging infectious diseases, including seasonal, avian, and pandemic influenza, SARS, MERS, and Ebola; antimicrobial resistance; development of the Pandemic Influenza Preparedness Framework; implementation of the International Health Regulations; food safety; and chronic fatigue syndrome.
|
From page 197... ...
Dr. Gellin has had broad experience in public health aspects of infectious diseases and has held positions at the National Institute of Allergy and Infectious Diseases, the U.S.
|
From page 198... ...
The PIP Framework has been instrumen g tal in strengthening global pandemic influenza preparedness and response capacities in countries where they are weak, and establishing agreements to provide to WHO access to critical pandemic response supplies, in real time, at the time of a pandemic. Jacqueline M
|
From page 199... ...
During that time, she also served on an interim basis as acting director of the National Center for Immunization and Respiratory Diseases, acting director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, and acting director of NCEZID during leadership transitions. Her previous CDC positions include director of the National Center for Preparedness, Detection, and Control of Infectious Diseases; director, acting director, and associate director for epidemiologic science in the National Center for Infectious Diseases (NCID)
|
From page 200... ...
In addition to her CDC position, she serves as clinical adjunct professor of medicine (infectious diseases) at Emory University.
|
From page 201... ...
He served as the Special Representative on Avian and Pandemic Influenza; Deputy Inspector General; Deputy U.S. Global AIDS Coordinator at the inception of the President's Emergency Plan for AIDS Relief; and U.S.
|
From page 202... ...
Lewin spent 7 years at Novartis Vaccines, most recently as vice president, head of medical affairs and immunization policy for North America, and was responsible for medical affairs activities and relationships with public-sector stakeholders such as the U.S. Centers for Disease Control and Prevention and the National Vaccine Program Office; in his role, he helped launch several vaccines.
|
From page 203... ...
Dr. Mazet specializes in emerging infectious diseases and wildlife epidemiology, and as director of OHI, focuses on global health problem solving.
|
From page 204... ...
Agency for International Development's Emerging Pandemic Threats Program. She leads a network of global NGOs and governmental agencies to build capacity within the PREDICT-engaged countries to develop surveillance systems and complete the necessary research to halt the next pandemic, like influenza, severe acute respiratory syndrome, Ebola, and HIV that have preceded the program.
|
From page 205... ...
Dr. Monto has been a member of the National Allergy and Infectious Diseases Advisory Council of the U.S.
|
From page 206... ...
He was past president of the American Epidemiological Society, the 2009 recipient of the Alexander Fleming Award of the Infectious Diseases Society of America for lifetime achievement, and the 2012 recipient of the Charles Merieux Award of the National Foundation for Infectious Diseases. He was a member of the emergency committee making recommendations to the World Health Organization during the most recent influenza pandemic.
|
From page 207... ...
Mr. Sands's engagement with global health issues includes: chairing the National Academy of Medicine's Commission on a Global Health Risk Framework for the Future, which in January 2016 produced the highly influential report The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Threats; chairing the World Bank's International Working Group on financing preparedness, which in May 2017 published From Panic and Neglect to Investing in Health Security: Financing Preparedness at a National Level; authoring several papers on infectious disease crises in the New England Journal of Medicine, The Lancet, and British Medical Journal; being the lead non-executive director between 2011 and 2017 on the Board of the United Kingdom's Department of Health, which provides oversight and policy direction to the United Kingdom's National Health Service; and being an active member on both the National Academy of Sciences' Committee on Ensuring Access to Affordable Drugs and the Forum on Microbial Threats.
|
From page 208... ...
in Geneva, Switzerland, where he focuses on WHO governance and international health law matters. He served as the WHO legal adviser to the negotiations that led to the Pandemic Influenza Preparedness (PIP)
|
From page 209... ...
He was also appointed as the ambassador extraordinary and pleni otentiary, permanent representative of Indonesia p to the United Nations in New York in 1997 to 2001, and ambassador extraordinary and plenipotentiary, permanent representative of Indonesia to the United Nations and other international organization in Geneva in 2004 to 2007. Ambassador Wibisono's recent activities include serving as the vice chairman of the Governing Board of the Indonesian Council of World Affairs, the former advisor of the National Commission on Human Rights, senior fellow of the Center for Strategic and International Studies, and currently as professor and lecturer at Airlangga University, the Defense University, the National Resilience Institute, and other various universities and institutions in Indonesia.
|
From page 210... ...
influenza pandemic, Dr. Zhang directed the laboratory response and capacity aspects of WHO response.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.